Tutkimusnäyttö eri
syöpälajeissa
Luu- lihas- ja siedekudossyöpä
Reynel MB, Villegas Y, Kiene H, Werthmann PG, Kienle GS. Long-term survival of a patient with recurrent dedifferentiated high-grade liposarcoma of the retroperitoneum under adjuvant treatment with Viscum album L. extract - A case report. Integr Cancer Ther. 2021 Jan-Dec;20. DOI: 10.1177/1534735421995258
Ostermann T, Appelbaum S, Poier D, Boehm K, Raak C and Büssing A. A Systematic Review and Meta-Analysis on the Survival of Cancer Patients Treated with a Fermented Viscum album L. Extract (Iscador): An Update of Findings. Complement Med Res. 2020 Jan 10:1-12. doi: 10.1159/000505202.
Kts. lisätietoja julkaisijan sivuilta
Longhi, A, Cesari, M, Serra, M, Mariani, E. Long-term follow-up of a randomized study of oral etoposide versus Viscum album fermentatum pini as maintenance therapy in osteosarcoma patients in complete surgical remission after second relapse. Sarcoma. 2020;2020:8260730. doi:10.1155/2020/8260730
Google Scholar | Crossref | Medline
Stammer RM, Kleinsimon S, Rolff J, Jäger S, Eggert A, Seifert G, Delebinski CI (2017) Synergistic antitumour properties of viscumTT in alveolar rhabdomyosarcoma. Journal of Immunology Research 2017. 13 pp. Article ID 4874280. DOI: 10.1155/2017/4874280
Waschakidze, T. Intraläsionale Misteltherapie bei einer Patientin mit Liposarkom – eine Fallvignette aus Georgien. Der Merkurstab. 2016;69(3):205-207. doi:10.14271/DMS-20638-DE
Google Scholar | Cross-ref
Longhi A, Reif M, Mariani E and Ferrari S. A Randomized Study on
Postrelapse Disease-Free Survival with Adjuvant Mistletoe versus Oral Etoposide in Osteosarcoma Patients. Evid Based Complement Alternat Med, 2014;2014:210198. DOI: 10.1155/2014/210198
Kirsch, A, Hajto, T. Case reports of sarcoma patients with optimized lectin-oriented mistletoe extract therapy. J Altern Complement Med. 2011;17(10):973-979. doi:10.1089/acm.2010.0596
Google Scholar | Crossref | Medline
Longhi A, Mariani E and Kuehn J J. A randomized study with adjuvant
mistletoe versus oral Etoposide on post relapse disease-free survival in osteosarcoma patients. Eur J Integr Med, 2009;1:31-39